Trexquant Investment LP Igm Biosciences, Inc. Transaction History

Trexquant Investment LP

  • $6.33 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$8.68 - $17.36 $209,856 - $419,712
24,177 New
24,177 $233,000
Q2 2023

Aug 11, 2023
BUY
$8.86 - $14.0 $207,208 - $327,418
23,387 New
23,387 $215,000
Q4 2021

Feb 14, 2022
SELL
$27.59 - $66.39 $93,254 - $224,398
-3,380 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$65.76 - $90.65 $222,268 - $306,397
3,380 New
3,380 $222,000

Others Institutions Holding IGMS

# of Institutions
89
Shares Held
21.4M
Call Options Held
39.5K
Put Options Held
16.5K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email